Polyphenols as potent epigenetics agents for cancer

P Rajendran, SA Abdelsalam, K Renu… - International journal of …, 2022 - mdpi.com
Human diseases such as cancer can be caused by aberrant epigenetic regulation.
Polyphenols play a major role in mammalian epigenome regulation through mechanisms …

Bone marrow microenvironment as a source of new drug targets for the treatment of acute myeloid leukaemia

KA Skelding, DL Barry, DZ Theron, LF Lincz - International journal of …, 2022 - mdpi.com
Acute myeloid leukaemia (AML) is a heterogeneous disease with one of the worst survival
rates of all cancers. The bone marrow microenvironment is increasingly being recognised as …

Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia

O Krali, Y Marincevic-Zuniga, G Arvidsson… - NPJ precision …, 2023 - nature.com
Genomic analyses have redefined the molecular subgrouping of pediatric acute
lymphoblastic leukemia (ALL). Molecular subgroups guide risk-stratification and targeted …

Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy

EWI Neuberger, S Sontag, A Brahmer, KFA Philippi… - Clinical …, 2022 - Springer
Physical activity impacts immune homeostasis and leads to rapid and marked increase in
cell-free DNA (cfDNA). However, the origin of cfDNA during exercise remains elusive and it …

[HTML][HTML] Methylation alterations and advance of treatment in lymphoma

MK Liu, XJ Sun, XD Gao, Y Qian, L Wang… - Frontiers in Bioscience …, 2021 - imrpress.com
Lymphoma is a common and aggressive form of hematopoietic malignancies with diverse
clinical and pathological features due to its heterogeneity. Although the current …

Targeting DNA methylation in leukemia, myelodysplastic syndrome, and lymphoma: a potential diagnostic, prognostic, and therapeutic tool

L Kalinkova, A Sevcikova, V Stevurkova… - International Journal of …, 2022 - mdpi.com
DNA methylation represents a crucial mechanism of epigenetic regulation in hematologic
malignancies. The methylation process is controlled by specific DNA methyl transferases …

Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia

K Kamachi, H Ureshino, T Watanabe, N Yoshida… - Cancer Letters, 2022 - Elsevier
ABL1 tyrosine kinase inhibitors (TKIs) dramatically improve the prognosis of chronic myeloid
leukemia (CML), but 10–20% of patients achieve suboptimal responses with low TKIs …

[PDF][PDF] 地西他滨/阿扎胞苷联合HAAG 方案治疗老年急性髓系白血病患者的临床疗效

赵晓东, 黄赛兰, 郑雨雨, 林国强, 张兴霞… - 临床血液学杂志, 2021 - lcxy.whuhzzs.com
目的: 回顾性对比观察及分析地西他滨/阿扎胞苷分别联合HAAG (高三尖杉酯碱HTT,
阿糖胞苷Ara-C, 阿克拉霉素Acla 及重组人粒细胞集落刺激因子G-CSF) 治疗无法接受强化疗的 …

Histone modifications and their targeting in lymphoid malignancies

M Fernández-Serrano, R Winkler, JC Santos… - International journal of …, 2021 - mdpi.com
In a wide range of lymphoid neoplasms, the process of malignant transformation is
associated with somatic mutations in B cells that affect the epigenetic machinery …

DNA methylation in T-cell acute lymphoblastic leukemia: in search for clinical and biological meaning

N Maćkowska, M Drobna-Śledzińska, M Witt… - International Journal of …, 2021 - mdpi.com
Distinct DNA methylation signatures, related to different prognosis, have been observed
across many cancers, including T-cell acute lymphoblastic leukemia (T-ALL), an aggressive …